by | May 6, 2025 | Lupus Foundation of America
New data highlights urgent need for improved education and diagnosis of lupus nephritis (lupus-related kidney disease), a serious complication of lupusA global survey conducted by the World Lupus Federation reveals that 47% of people living with lupus report kidney...
by | May 1, 2025 | Lupus Foundation of America
New Lupus Foundation of America survey shines a light on cruel and mysterious disease during Lupus Awareness MonthA new survey commissioned by the Lupus Foundation of America (LFA) for Lupus Awareness Month in May, reveals that lupus remains mostly unknown and...
by | Apr 29, 2025 | Lupus Foundation of America, News & Events
A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus Erythematosus (SLE). Preliminary data suggests that CAR-T therapy may significantly improve both serologic and clinical outcomes in people with SLE,...
by | Apr 29, 2025 | Lupus Foundation of America, News & Events
In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status in women with systemic lupus erythematosus (SLE). The cross-sectional study consisted of 46 premenopausal women between the ages of 18 and 40...
by | Apr 28, 2025 | Lupus Foundation of America, News & Events
Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819. This designation signifies that a therapy meets specific requirements...
by | Apr 24, 2025 | Lupus Foundation of America, News & Events
A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease (CVD) risk prediction in women with systemic lupus erythematosus (SLE). CVD is a significant concern for individuals with SLE, accounting for...
